FDA Withdraws Advance Notice of Proposed Rulemaking for Needle-Bearing Devices

Summary

The Food and Drug Administration (FDA) has withdrawn its advance notice of proposed rulemaking (ANPRM) concerning needle-bearing devices, citing that existing actions by the agency and the Occupational Safety and Health Administration (OSHA) are sufficient to address the significant health risk posed by needlestick and other percutaneous injuries.